Akebia therapeutics, inc. (AKBA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenues:
Total revenues

335,001

207,742

181,227

1,535

-

-

-

-

Cost of goods sold:
Product

108,935

6,251

-

-

-

-

-

-

Amortization of intangibles

36,401

1,517

-

-

-

-

-

-

Total cost of goods sold

145,336

7,768

-

-

-

-

-

-

Operating expenses:
Research and development

322,969

291,007

230,893

115,785

43,016

23,263

8,902

5,632

Selling, general and administrative

149,455

87,061

27,008

22,210

18,497

14,677

7,031

2,891

License expense

3,529

67

-

-

-

-

-

-

Total operating expenses

475,953

378,135

257,901

137,995

61,513

37,940

15,933

8,523

Operating loss

-286,288

-178,161

-76,674

-136,460

-61,513

-37,940

-15,933

-8,523

Other income (expense):
Interest income (expense)

792

6,154

2,799

901

510

206

-704

-1,644

Other income (expense)

-794

81

204

-188

287

700

1,050

-

Net loss before income taxes

-286,290

-171,926

-73,671

-135,747

-

-

-

-

Benefit from income taxes

-6,631

-28,338

-

-

-

-

-

-

Extinguishment of debt and other liabilities

-

-

-

-

-

-

2,420

-

Reimbursements from Aerpio

-

-

-

-

-

-

-

1,971

Net loss

-279,659

-143,588

-73,671

-135,747

-60,716

-37,034

-13,167

-8,196

Accretion on preferred stock

-

-

-

-

-

86,899

55,886

3,323

Net loss applicable to common stockholders - basic and diluted

-

-

-

-

-

-123,933

-69,053

-11,519

Net loss per share - basic and diluted

-2.36

-2.47

-1.69

-3.60

-2.29

-8.04

-126.94

-27.82

Weighted-average number of common shares - basic and diluted

118,395

58,038

43,500

37,716

26,469

15,406

544

414

Net loss

-279,659

-143,588

-73,671

-135,747

-60,716

-37,034

-13,167

-8,196

Other comprehensive gain - unrealized gain on debt securities

261

181

-400

-42

-234

-56

-

-

Total comprehensive loss

-279,398

-143,407

-74,071

-135,789

-60,950

-37,090

-13,167

-8,196

Product Revenue, Net
Total revenues

111,119

6,824

-

-

-

-

-

-

License, Collaboration and Other Revenue
Total revenues

223,882

200,918

181,227

1,535

-

-

-

-